Fu Zebang – Trademark Portfolio

Entity Type: 01

Fu Zebang holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 34 (Smokers Articles) — 2 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include FQWJMO, XMWGNI, and LAOKSFZ. The owner is based in Zhanjiang,Guangdong.

Room 101, No.8, Chengjiawai Village

Mazhang Town, Mazhang District

Zhanjiang,Guangdong 524000 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

FQWJMO
FQWJMO
Registered 2021
FQWJMO
FQWJMO
Registered 2021
XMWGNI
XMWGNI
Registered 2021
LAOKSFZ
LAOKSFZ
Registered 2021

Trademark Classifications

Fu Zebang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

34
Smokers Articles (2 filings)

Tobacco; smokers articles; matches

25
Clothing (1 filing)

Clothing, footwear, headgear

21
Housewares (1 filing)

Household or kitchen utensils and containers; combs and sponges; brushes

Frequently Asked Questions

How many trademarks does Fu Zebang have?

Fu Zebang has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does Fu Zebang file in?

Fu Zebang files trademarks across 3 Nice Classification classes. The most active classes are Class 34 (Smokers Articles), Class 25 (Clothing), Class 21 (Housewares). Class 34 covers tobacco; smokers articles; matches.

What are Fu Zebang's most well-known trademarks?

Fu Zebang's registered trademark portfolio includes well-known marks such as FQWJMO, XMWGNI, and LAOKSFZ. These are among 4 currently registered trademarks in the portfolio.

What is Fu Zebang's trademark registration success rate?

Fu Zebang has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.